Prior work suggests that MMP-9 in the blood can indirectly promote AD pathogenesis, by damaging tight junction proteins and endothelial cells, making the blood-brain barrier more permeable to blood-derived neurotoxic molecules, leading to a neuroinflammatory cascade that promotes the accumulation of AD pathology [7]. The gene discussed is MMP9; the disease is Alzheimer disease.